RL
Live price temporarily unavailable.
Price history
Relay Therapeutics Inc (RLAY) is a Health Care company in the Russell 2000. Latest news and coverage below.
IPO: July 16, 2020 · $20.00 offering · NASDAQ · View IPO details →
Recent News (3)
-
Relay Therapeutics CFO Sells 17,717 Shares for $350,000
Relay Therapeutics CFO Sells 17,717 Shares for $350,000
-
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapi…
-
H.C. Wainwright raises Relay Therapeutics price target to $29
H.C. Wainwright raises Relay Therapeutics price target to $29
More Health Care stocks
- AZN AstraZeneca
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- AMGN Amgen
- BAX Baxter International